查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1643985

全球器官保存解决方案市场：2033 年的机会与策略

Organ Preservation Solution Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 315 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018 年全球器官保存解决方案市值为 2.1796 亿美元，预计到 2023 年复合年增长率将超过 4.00%。

器官移植数量增加

迄今为止，器官移植手术数量的增加推动了器官保存解决方案市场的成长。移植手术的数量不断增加，尤其是在美国和印度等地区，推动了对有效器官保存解决方案的需求，以维持器官活力、减少劣化并提高成功率。这种激增促使医疗保健提供者投资先进的保存技术，以满足日益增长的器官捐赠量。随着移植手术频率的增加，器官保存解决方案市场持续成长，有助于提高移植成功率和医疗保健基础设施。例如，2023年2月，在印度国家器官和组织移植组织（NOTTO）举行的2023年科学对话会上，印度政府卫生和家庭福利部下属的联邦卫生部长组织召开了一场盛大的会议，汇集了医学界和科学界的专家，共同探讨器官和组织移植的最新移植进展。同时，器官移植数量也以每年27%的大幅成长态势出现在中国，凸显了中国器官移植能力的提升和医疗保健基础设施的不断扩大。此外，根据管理器官移植系统的美国民间非营利组织联合国器官共享网络（UNOS）2023年1月发布的快报资料，美国2022年器官移植数量创下新高，达42887例，比2021年增长3.7%。肾臟移植例数首次突破2.5万例，总合达25,498例，与前一年同期比较增加3.4%。此外，肝臟移植（9,528例）、心臟移植（4,111例）和肺移植（2,692例）数量也均创历史新高，反映出该国器官移植能力的显着增加。因此，器官移植手术数量的增加促进了器官保存解决方案市场的成长。

目录

第一章执行摘要

  • 器官保存解决方案-市场吸引力和宏观经济状况

第 2 章 目录

第 3 章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 器官保存解决方案市场定义与细分
  • 按解决方案类型细分的市场
    • Viaspan(TM)
    • Custodiol HTK（组胺酸-色胺酸-酮戊二酸）
    • Renograf
    • 低温
    • Perfadex
    • 改革
    • HBS（高渗透压血液替代物）溶液
    • 其他解决方案类型
  • 按器官细分的市场
    • 肾
    • 肝
    • 肺
    • 心
    • 其他器官类型
  • 按技术细分的市场
    • 静态冷冻 (SCS) 技术
    • 低温机灌注
    • 其他技术

第七章：主要市场趋势

  • 策略性投资旨在加速下一代器官保存技术的监管核准和市场准入
  • 主要企业之间的策略联盟与收购
  • 新研发中心将彻底改变器官保存技术并增强全球医疗保健解决方案

第 8 章 器官保存解决方案市场：宏观经济情景

  • COVID-19 影响：器官保存解决方案市场
  • 乌克兰战争的影响：器官保存解决方案市场
  • 高通膨的影响：器官保存解决方案市场

第九章 全球市场规模及成长

  • 市场规模
  • 2018 年至 2023 年市场成长表现
    • 市场驱动因素 2018-2023
    • 2018-2023 年市场限制
  • 2023-2028 年及 2033 年市场成长预测
    • 市场驱动因素 2023-2028
    • 市场限制 2023-2028

第 10 章。

  • 全球器官保存解决方案市场（按解决方案类型、性能和预测），2018-2023 年、2028 年预测、2033 年预测
  • 全球器官保存解决方案市场：按器官、绩效和预测，2018-2023 年、2028 年预测、2033 年预测
  • 全球器官保存解决方案市场（按技术、绩效和预测），2018-2023 年、2028 年预测、2033 年预测

第 11 章 器官保存解决方案市场：区域与国家分析

  • 全球器官保存解决方案市场：按地区、绩效和预测，2018-2023 年、2028 年预测、2033 年预测
  • 全球器官保存解决方案市场：按国家、表现和预测，2018-2023 年、2028 年预测、2033 年预测

第十二章 亚太市场

第十三章 西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第 18 章：非洲市场

第十九章竞争格局与公司概况

  • 公司简介
  • TransMedics Group, Inc
  • BioLife Solutions, Inc
  • Artivion, Inc.（Formerly CryoLife, Inc.）
  • Paragonix Technologies Inc
  • XVIVO Perfusion AB

第 20 章 其他大型创新企业

  • Essential Pharmaceuticals LLC（Intas Pharmaceuticals Limited（Accord Healthcare Inc.））
  • 1.2 Bristol-Myers Squibb Company
  • OrganOx Limited
  • Gennova Biopharmaceuticals Ltd.
  • Preservation Solutions, Inc.
  • TX Innovations
  • Shanghai Genext Medical Technology Company（Lifeline Scientific, Inc.）
  • Global Transplant Solutions
  • BioCydex
  • Dr. Franz Kohler Chemie GmbH
  • SALFSpA Laboratorio Farmacologico
  • Groupe IGL（known as IGL）
  • X-THERMA INC.
  • Lineage Cell Therapeutics, Inc.（BioTime, Inc.）
  • Vascular Perfusion Solutions Inc.

第 21 章 竞争性基准化分析

第 22 章 竞争仪錶板

第23章 重大併购

  • Getinge Acquired Paragonix Technologies

第24章机会与策略

  • 2028 年全球器官保存解决方案市场：提供新机会的国家
  • 2028 年全球器官保存解决方案市场：提供新机会的细分市场
  • 2028 年全球器官保存解决方案市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 25 章器官保存解决方案市场：结论与建议

  • 结论
  • 建议
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第26章 附录

简介目录
Product Code: o&s1448

Organ preservation solutions are specialized medical preparation designed to maintain the viability of organs outside the body before they are transplanted into a recipient. These solutions are used predominantly within organ transplantation procedures to extend the time organs can be maintained ex vivo, thus enhancing the chance of a successful transplant and reducing the risk of organ damage due to ischemia, a condition that occurs when blood flow to an organ is restricted or ceased, which can lead to a shortage of oxygen and essential nutrients.

The organ preservation solution market consists of sales by entities (organizations, sole traders and partnerships), of organ preservation solutions that are primarily used by hospitals, transplant centers and surgical teams that manage donor organs for patients in need of transplants due to organ failure or injury. Additionally, these solutions play a critical role in the overall organ donation and transplantation ecosystem, supporting organ viability from the time of procurement from a donor to implantation into the recipient.

The global organ preservation solution market was valued at $217.96 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.00%.

Rise In Number Of Organ Transplant Surgeries

The rise in the number of organ transplant surgeries boosted the growth of the organ preservation solution market during this historic period. The increase in transplant surgeries, especially in regions like the US and India, has driven demand for effective organ preservation solutions to maintain organ viability, reduce deterioration and improve success rates. This surge has prompted healthcare providers to invest in advanced preservation technologies, addressing the growing volume of organ donations. As transplant procedures become more frequent, the market for organ preservation solutions continues to expand, supporting higher transplant success rates and improved healthcare infrastructure. For example, in February 2023, at the "National Organ and Tissue Transplant Organisation (NOTTO), Scientific Dialogue 2023," a prestigious conference that brings together experts from the medical and scientific communities to discuss the latest advancements in organ and tissue transplantation, organized by the Union Health Secretary, a body under the Ministry of Health and Family Welfare, Government of India, India experienced a rapid resurgence in organ transplant activities following the COVID-19 pandemic, surpassing 15,000 transplants in 2022 for the first time. This growth was accompanied by a significant annual increase of 27% in transplant numbers, highlighting the country's improving transplant capabilities and expanding healthcare infrastructure. Additionally, in January 2023, according to preliminary data from the United Network for Organ Sharing (UNOS), a US-based private, non-profit organization that manages the organ transplantation system, in 2022, the United States achieved a new record with 42,887 organ transplants, marking a 3.7% increase over 2021. For the first time, more than 25,000 kidney transplants were performed, totaling 25,498, a 3.4% rise from the previous year. Additionally, record-high numbers were recorded for liver (9,528), heart (4,111) and lung (2,692) transplants, reflecting significant growth in the nation's organ transplant capabilities. Therefore, the rise in the number of organ transplant surgeries contributed to the growth of the organ preservation solution market.

Strategic Investment To Drive Regulatory Approval And Market Entry For Next-Generation Organ Preservation Technologies

Major companies in the organ preservation solution market are securing investments to fund regulatory approval, clinical trials and production scaling. These efforts aim to introduce advanced technologies that improve organ viability, reduce rejection rates and expand the organ donor pool, ultimately enhancing transplant success rates globally. For instance, in April 2024, Vivalyx, a Germany-based biotech company that produces a preservation liquid for optimal organ preservation before transplant, secured a €5.4 million ($5.79 million) seed round. The funds raised will be allocated towards financing the required clinical trials to obtain regulatory clearance and initiate commercialization. This financing round marks a crucial step toward bringing the company's products to market. The company recognizes significant potential in its innovations to transform the global organ transplantation industry.

The global organ preservation solution market is highly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 4.86% of the total market in 2023.

Organ Preservation Solution Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organ preservation solution market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organ preservation solution? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organ preservation solution market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organ preservation solution market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by solution type, by organ and by technique.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organ preservation solution market.

Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by solution type, by organ type and by technique in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organ preservation solution providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Solution Type: Viaspan; Custodial-HTK (Histidine-Tryptophan-Ketoglutarate); Renograf; Hypothermosol; Perfadex; Lifor; HBS (Hyperosmotic Blood Substitute) Solution; Other Solution Types
  • 2) By Organ: Kidney; Liver; Lung; Heart; Other Organ Types
  • 3) By Technique: Static Cold Storage (SCS) Technique; Hypothermic Machine Perfusion; Other Techniques
  • Companies Mentioned: TransMedics Group, Inc.; BioLife Solutions, Inc.; Artivion, Inc. (formerly CryoLife, Inc.); Paragonix Technologies Inc.; XVIVO Perfusion AB
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organ preservation solution indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organ Preservation Solution - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organ Preservation Solution Market Definition And Segmentations
  • 6.4 Market Segmentation By Solution Type
    • 6.4.1 Viaspan(TM)
    • 6.4.2 Custodiol HTK (Histidine- Tryptophan - Ketoglutarate)
    • 6.4.3 Renograf
    • 6.4.4 Hypothermosol
    • 6.4.5 Perfadex
    • 6.4.6 Lifor
    • 6.4.7 HBS (Hyperosmotic Blood Substitute) Solution
    • 6.4.8 Other Solution Types
  • 6.5 Market Segmentation By Organ
    • 6.5.1 Kidney
    • 6.5.2 Liver
    • 6.5.3 Lung
    • 6.5.4 Heart
    • 6.5.5 Other Organ Types
  • 6.6 Market Segmentation By Technique
    • 6.6.1 Static Cold Storage (SCS) Technique
    • 6.6.2 Hypothermic Machine Perfusion
    • 6.6.3 Other Techniques

7 Major Market Trends

  • 7.1 Strategic Investment To Drive Regulatory Approval And Market Entry For Next-Generation Organ Preservation Technologies
  • 7.2 Strategic Partnerships And Acquisitions Among Major Players
  • 7.3 New Research And Development Center To Revolutionize Organ Preservation Techniques And Enhance Global Healthcare Solutions

8 Organ Preservation Solution Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Organ Preservation Solution Market
  • 8.2 Impact Of The War In Ukraine On The Organ Preservation Solution Market
  • 8.3 Impact Of High Inflation On The Organ Preservation Solution Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Organ Preservation Solution Market Segmentation

  • 10.1 Global Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Organ Preservation Solution Market, Regional and Country Analysis

  • 11.1 Global Organ Preservation Solution Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Organ Preservation Solution Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia Pacific Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia Pacific Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia Pacific Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Organ Preservation Solution Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Major Companies
  • 12.10 China Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Organ Preservation Solution Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major companies
  • 14.3 Eastern Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Organ Preservation Solution Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 USA Market
  • 15.7 Summary
  • 15.8 Market Overview
    • 15.8.1 Country Information
    • 15.8.2 Market Information
    • 15.8.3 Background Information
    • 15.8.4 Government Initiatives
    • 15.8.5 Regulations
    • 15.8.6 Regulatory Bodies
    • 15.8.7 Major Associations
    • 15.8.8 Taxes Levied
    • 15.8.9 Corporate Tax Structure
    • 15.8.10 Investments
    • 15.8.11 Major Companies
  • 15.9 USA Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 Canada Market
  • 15.13 Canada Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 South America Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 Brazil Market
  • 16.7 Brazil Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Major Companies
  • 17.3 Middle East Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Major Companies
  • 18.3 Africa Organ Preservation Solution Market, Segmentation By Solution Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Organ Preservation Solution Market, Segmentation By Organ, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Organ Preservation Solution Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 TransMedics Group, Inc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 BioLife Solutions, Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Financial Overview
  • 19.4 Artivion, Inc. (Formerly CryoLife, Inc.)
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Paragonix Technologies Inc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial Overview
  • 19.6 XVIVO Perfusion AB
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Essential Pharmaceuticals LLC (Intas Pharmaceuticals Limited (Accord Healthcare Inc.))
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 1.2 Bristol-Myers Squibb Company
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 OrganOx Limited
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Gennova Biopharmaceuticals Ltd.
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Preservation Solutions, Inc.
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 TX Innovations
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Shanghai Genext Medical Technology Company (Lifeline Scientific, Inc.)
    • 20.7.1 Company Overview
    • 20.7.2 Products & Services
  • 20.8 Global Transplant Solutions
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 BioCydex
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Dr. Franz Kohler Chemie GmbH
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 S.A.L.F. S.p.A. Laboratorio Farmacologico
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Groupe IGL (known as IGL)
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 X-THERMA INC.
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Lineage Cell Therapeutics, Inc. (BioTime, Inc.)
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 Vascular Perfusion Solutions Inc.
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Getinge Acquired Paragonix Technologies

24 Opportunities And Strategies

  • 24.1 Global Organ Preservation Solution Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Organ Preservation Solution Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Organ Preservation Solution Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Organ Preservation Solution Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer